SEC 13F Intelligence

Phoenix Financial Ltd. / ALXN

Phoenix Financial Ltd.’s Alexion Pharmaceuticals Inc Position

Does Phoenix Financial Ltd. own Alexion Pharmaceuticals Inc (ALXN)? Not currently — the last reported position was 162.9K shares worth $30M in Q2 2021; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$30M
Q2 2021
Shares
162.9K
% of Portfolio
+0.57%
Quarters Held
7
position exited

Position History ALXN

Reported value by quarter
Q3 ’19: $18MQ3 ’19Q4 ’19: $19MQ4 ’19Q1 ’20: $19MQ1 ’20Q2 ’20: $27MQ2 ’20Q4 ’20: $29MQ4 ’20Q1 ’21: $25MQ1 ’21Q2 ’21: $30MQ2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2021162.9K$30M+0.57%
Q1 2021160.6K$25M+0.56%
Q4 2020184.7K$29M+0.77%
Q2 2020254.7K$27M+1.15%
Q1 2020214.7K$19M+0.95%
Q4 2019174.7K$19M+0.78%
Q3 2019192.9K$18M+0.85%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Phoenix Financial Ltd.’s full portfolio or all institutional holders of ALXN.